TOPICAL COMPOSITION FOR USE IN TREATING CUTANEOUS LEISHMANIASIS
The present invention relates to a composition comprising a combination of a (halogenoacetamido)benzoate, a flavonol derivative and a terpene derivative, and, as exemple, relates to a composition comprising the combination of ethyl 3-(2-chloroacetamido)benzoate, dihydroquercetin and bisabolol. Said...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
06.03.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a composition comprising a combination of a (halogenoacetamido)benzoate, a flavonol derivative and a terpene derivative, and, as exemple, relates to a composition comprising the combination of ethyl 3-(2-chloroacetamido)benzoate, dihydroquercetin and bisabolol. Said composition is for use in the treatment of leishmaniasis, especially cutaneous or mucosal leishmaniasis, the composition being applied topically for concomitantly treating both parasitic infection and skin inflammation of the infected area induced by leishmaniasis. |
---|---|
Bibliography: | Application Number: EP20170306143 |